Terms: = Colorectal cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Prognosis
19 results:
1. Is radiotherapy necessary for upper rectal cancer underwent curative resection? A retrospective study of 363 patients.
Ma Z; Zhou J; Liu K; Chen S; Wu Q; Peng L; Zhao W; Zhu S
Radiat Oncol; 2024 Jan; 19(1):8. PubMed ID: 38238776
[TBL] [Abstract] [Full Text] [Related]
2. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
Pyo JS; Kim NY; Min KW; Kang DW
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
[No Abstract] [Full Text] [Related]
3. Clinical Significance of Combining Preoperative and Postoperative Albumin-Bilirubin Score in colorectal cancer.
Kim D; Lee JH; Cho ES; Shin SJ; Lee HS; Koh HH; Lee KY; Kang J
Cancer Res Treat; 2023 Oct; 55(4):1261-1269. PubMed ID: 37080608
[TBL] [Abstract] [Full Text] [Related]
4. No association between genetically predicted C-reactive protein levels and colorectal cancer survival in Korean: two-sample Mendelian randomization analysis.
Choi CK; Yang JH; Shin MH; Cho SH; Kweon SS
Epidemiol Health; 2023; 45():e2023039. PubMed ID: 36996866
[TBL] [Abstract] [Full Text] [Related]
5. Morbidity and long-term results in patients with wild and mutant type Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations undergoing colorectal cancer surgery.
Aziret M; Subasi O; Bilir C; Tozlu M; Altıntoprak F; Karaman K; Ercan M; Celebi F
Ann Ital Chir; 2022; 92():65-77. PubMed ID: 35342104
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German cancer Consortium-Radiation Oncology Group (DKTK-ROG).
Martin D; Schreckenbach T; Ziegler P; Filmann N; Kalinauskaite G; Tinhofer I; Budach V; Gani C; Zips D; Schimek-Jasch T; Schäfer H; Grosu AL; Thomas E; Krause M; Dapper H; Combs S; Hoffmann C; Stuschke M; Walter F; Belka C; Kurth I; Hadiwikarta WW; Baumann M; Rödel C; Fokas E
Radiother Oncol; 2022 Feb; 167():233-238. PubMed ID: 34999135
[TBL] [Abstract] [Full Text] [Related]
7. Association of miR-21 and miR-335 to microsatellite instability and prognosis in stage III colorectal cancer.
Calvo-López T; Paz-Cabezas M; Llovet P; Ibañez MD; Sastre J; Alonso-Orduña V; Viéitez JM; Yubero A; Vera R; Asensio-Martínez E; Garcia-Alfonso P; Aranda E; Diaz-Rubio E; Perez-Villamil B
Cancer Biomark; 2022; 34(2):201-210. PubMed ID: 34958006
[TBL] [Abstract] [Full Text] [Related]
8. Patients with mesenchymal tumours and high
Salvucci M; Crawford N; Stott K; Bullman S; Longley DB; Prehn JHM
Gut; 2022 Aug; 71(8):1600-1612. PubMed ID: 34497144
[TBL] [Abstract] [Full Text] [Related]
9. Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study.
Yamashita R; Long J; Longacre T; Peng L; Berry G; Martin B; Higgins J; Rubin DL; Shen J
Lancet Oncol; 2021 Jan; 22(1):132-141. PubMed ID: 33387492
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p.
Su YZ; Cui MF; Du J; Song B
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1158-1167. PubMed ID: 32096164
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of CpG island methylator phenotype among hepatocellular carcinoma patients: A systematic review and meta-analysis.
Wang Q; Wang G; Liu C; He X
Int J Surg; 2018 Jun; 54(Pt A):92-99. PubMed ID: 29698791
[TBL] [Abstract] [Full Text] [Related]
12. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
GabAllah GMK; El-Din Habib MS; Soliman SE; Kasemy ZA; Gohar SF
Saudi J Gastroenterol; 2017; 23(6):348-356. PubMed ID: 29205188
[TBL] [Abstract] [Full Text] [Related]
13. Dietary factors and polymorphisms in vitamin D metabolism genes: the risk and prognosis of colorectal cancer in northeast China.
Gong C; Long Z; Yu Y; Zhu L; Tian J; Li S; Li J; Yu H; Chi Q; Piao D; Wang F; Zhao Y; Cui B
Sci Rep; 2017 Aug; 7(1):8827. PubMed ID: 28821819
[TBL] [Abstract] [Full Text] [Related]
14. Complete mesocolic excision an assessment of feasibility and outcome.
Bertelsen CA
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157065
[TBL] [Abstract] [Full Text] [Related]
15. Associations of ABCB1 and XPC genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population.
Yue AM; Xie ZB; Zhao HF; Guo SP; Shen YH; Wang HP
Asian Pac J Cancer Prev; 2013; 14(5):3085-91. PubMed ID: 23803084
[TBL] [Abstract] [Full Text] [Related]
16. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
[TBL] [Abstract] [Full Text] [Related]
17. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.
Yang XQ; Chen C; Peng CW; Liu SP; Li Y
Med Oncol; 2012 Jun; 29(2):1030-6. PubMed ID: 21553105
[TBL] [Abstract] [Full Text] [Related]
18. Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification.
Dekker JW; Peeters KC; Putter H; Vahrmeijer AL; van de Velde CJ
Eur J Surg Oncol; 2010 Dec; 36(12):1180-6. PubMed ID: 20884164
[TBL] [Abstract] [Full Text] [Related]
19. Identification of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility.
Frances CP; Conde MC; Saez ME; Diez SF; Rey CM; Ramírez-Armengol JA; Pascual MH; Gonzalez-Perez A; Torres PP; Real LM; Serrano-Rios M; López JL; Ruiz A; Royo JL
J Gastroenterol Hepatol; 2007 Dec; 22(12):2298-302. PubMed ID: 17559371
[TBL] [Abstract] [Full Text] [Related]
